Literature DB >> 19817074

Anxiety in medically ill patients.

Rajnish Mago1, John-Paul Gomez, Namita Gupta, Elisabeth J S Kunhel.   

Abstract

Anxiety disorders and anxiety symptoms are highly prevalent in the general population and more so in the medically ill. They have a number of negative consequences for these patients and may worsen the outcome of the medical illness and increase health care utilization. In the evaluation of these patients, it is of paramount importance to identify the etiology of the anxiety and, in particular, to differentiate primary from secondary anxiety. Management includes medications (especially benzodiazepines and selective serotonin reuptake inhibitors) and psychotherapy (particularly cognitive-behavioral therapy).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 19817074     DOI: 10.1007/s11920-006-0028-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  42 in total

1.  One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease.

Authors:  M E Kunik; U Braun; M A Stanley; K Wristers; V Molinari; D Stoebner; C A Orengo
Journal:  Psychol Med       Date:  2001-05       Impact factor: 7.723

2.  Early coadministration of clonazepam with sertraline for panic disorder.

Authors:  A W Goddard; T Brouette; A Almai; P Jetty; S W Woods; D Charney
Journal:  Arch Gen Psychiatry       Date:  2001-07

Review 3.  An overview of psychotropic drug-drug interactions.

Authors:  Neil B Sandson; Scott C Armstrong; Kelly L Cozza
Journal:  Psychosomatics       Date:  2005 Sep-Oct       Impact factor: 2.386

4.  Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study.

Authors:  Elaine D Eaker; Lisa M Sullivan; Margaret Kelly-Hayes; Ralph B D'Agostino; Emelia J Benjamin
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

5.  Some drugs that cause psychiatric symptoms.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1998-02-13       Impact factor: 1.909

6.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

7.  Quality of care for primary care patients with anxiety disorders.

Authors:  Murray B Stein; Cathy D Sherbourne; Michelle G Craske; Adrienne Means-Christensen; Alexander Bystritsky; Wayne Katon; Greer Sullivan; Peter P Roy-Byrne
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

8.  Generalized anxiety disorder in stroke patients. A 3-year longitudinal study.

Authors:  M Aström
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

9.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

10.  Physician office visits of adults for anxiety disorders in the United States, 1985-1998.

Authors:  Jeffrey S Harman; Bruce L Rollman; Barbara H Hanusa; Eric J Lenze; M Katherine Shear
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

View more
  2 in total

1.  Anxiety in the Medically Ill: A Systematic Review of the Literature.

Authors:  Sara Romanazzo; Giovanni Mansueto; Fiammetta Cosci
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

2.  Hypothalamic deep brain stimulation as a strategy to manage anxiety disorders.

Authors:  Han-Tao Li; Dane C Donegan; Daria Peleg-Raibstein; Denis Burdakov
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-11       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.